NCT07010783 Respiratory Functions in Parkinson's Disease
| NCT ID | NCT07010783 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara University |
| Condition | Parkinson Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-07-01 |
| Primary Completion | 2026-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-07-01 with a primary completion date of 2026-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim is to examine respiratory functions, inspiratory muscle strength, respiratory function, physical fitness and aerobic capacity in Parkinson's disease patients. Individuals between the ages of 50-80 who have been diagnosed with Parkinson's disease by a neurologist and healthy individuals with similar demographic characteristics will be included in the study as a control group. In addition, patients will be divided into three groups as above and below 2.5 and healthy controls according to the Modified Hoehn and Yahr Scale. Demographic information of the individuals will be recorded and clinical evaluations will be made. The staging of Parkinson's patients will be done with the Modified Hoehn and Yahr Scale, and the severity of the disease will be done with the Unified Parkinson's Disease Rating Scale. The inspiratory muscle strength of the individuals will be evaluated with the PowerBreath K5, respiratory functions with the Pulmonary Function Test device, and physical fitness and aerobic capacity with the Senior Fitness Test.
Eligibility Criteria
Inclusion Criteria: * Age 50 to 80 * Mini Mental State Examination score of 24 to 30 * Diagnosed with Parkinson's Disease by a neurologist Exclusion Criteria: * Sözlü iletişim kuramama * Yürüme yardımcısı kullanıma * Ciddi görme bozukluğu, ek nörolojik bozuklukları ve/veya konjestif kalp yetmezliği olan yaşlılar * Egzersiz yapılması tavsiye edilmeyen yaşlı yetişkinler.
Contact & Investigator
Süleyman Korkusuz, PhD
STUDY CHAIR
Atılım University
Frequently Asked Questions
Who can join the NCT07010783 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, up to 80 Years, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07010783 currently recruiting?
Yes, NCT07010783 is actively recruiting participants. Contact the research team at bskorkusuz@ankara.edu.tr for enrollment information.
Where is the NCT07010783 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07010783 clinical trial?
NCT07010783 is sponsored by Ankara University. The principal investigator is Süleyman Korkusuz, PhD at Atılım University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.